Home / MissionIR Articles

MissionIR Articles

  • Capricor Therapeutics (CAPR) Presents at Rodman & Renshaw Conference

    Capricor Therapeutics, Inc. (NASDAQ: CAPR)is focused on discovering, developing and marketing first-in-class therapeutics for the treatment of diseases. Presently, the company is positioned at the forefront of one of the largest segments of the U.S.…

  • Capnia (CAPN) Presents at Rodman & Renshaw Conference

    Capnia, Inc. (NASDAQ: CAPN) develops diagnostic and therapeutic products based on its proprietary technology for the precision metering of gas flow. Operating primarily in the U.S., the company offers CoSense for the diagnosis of excessive…

  • Can-FiteBioPharma (CANF) Presents at Rodman & Renshaw Conference

    Can-FiteBioPharma Ltd. (NYSE: CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase II and III clinical development stage,…

  • Cadiz (CDZI) Presents at Rodman & Renshaw Conference

    Founded more than 25 years ago, Cadiz Inc. (NASDAQ: CDZI) is a Los Angeles-based renewable resource company dedicated to pursuing sustainable projects through the responsible stewardship of its land and water resources. The company owns…

  • Matinas BioPharma Holdings, Inc. (MTNB) Utilizing Proprietary Technology to Improve Safety Profile of Existing Drugs

    Matinas Biopharma Holdings is a clinical-stage biopharmaceutical company focused on the development of safe and effective broad spectrum antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections. The company’s proprietary, disruptive technology…

  • Brainstorm Cell Therapeutics (BCLI) Presents at Rodman & Renshaw Conference

    Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI)is developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases, e.g. Amyotrophic Lateral Sclerosis (ALS a.k.a. Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s disease (PD). NurOwn is…

  • BioTime (BTX) Presents at Rodman & Renshaw Conference

    BioTime, Inc. (NYSE: BTX) is building a dominant company in the field of regenerative medicine. The company’s strategy is to be the leader in the development of pluripotent stem cell-based technologies and to apply those…

  • Biota Pharmaceuticals (BOTA) Presents at Rodman & Renshaw Conference

    Biota Pharmaceuticals, Inc. (NASDAQ: BOTA) is focused on discovering and developing direct-acting antivirals to treat infections that affect a significant number of patients globally. The company has four product candidates with limited therapeutic options in…

  • BioSpecifics Technologies (BSTC) Presents at Rodman & Renshaw Conference

    BioSpecifics Technologies Corp. (NASDAQ: BSTC) is a profitable, commercial-stage biopharmaceutical company that has developed injectable collagenase for 12 clinical indications to date. Injectable collagenase is approved for marketing as XIAFLEX (collagenase clostridium histolyticum or CCH)…

  • BioPharmX (BPMX) Presents at Rodman & Renshaw Conference

    Through its patented platform technologies, BioPharmX Corporation (NYSE MKT: BPMX) develops unique health and wellness products for licensing and commercialization in pharmaceutical, over-the-counter and supplemental use. The BioPharmX team aims to touch lives by providing…

  • BiondVax Pharmaceuticals (BVXV) Presents at Rodman & Renshaw Conference

    BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), an innovative biopharmaceutical company, is developing a universal flu vaccine designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains.…

  • BioMark Diagnostics (BMKDF) Presents at Rodman & Renshaw Conference

    BioMark Diagnostics, Inc. (OTCQB: BMKDF) is an oncology-focused company on a mission to develop and market cutting-edge technologies to increase prediction and accuracy in the diagnosis of cancers. The company develops metabolomics-based diagnostic assays for…

  • BioLineRx (BLRX) Presents at Rodman & Renshaw Conference

    Israel-based BioLineRx Ltd. (NASDAQ: BLRX) is a clinical-stage biopharmaceutical company committed to identifying, in-licensing and developing promising therapeutic candidates. The company in-licenses novel compounds primarily from academic institutions and biotech companies based in Israel, develops…

  • BioLife Solutions (BLFS) Presents at Rodman & Renshaw Conference

    BioLife Solutions, Inc. (NASDAQ: BLFS) is located in Bothell, Washington, on a high-tech campus that has roots as a dairy farm. The company manufactures and markets proprietary protein-free, serum-free cGMP biopreservation media for cells, tissues…

  • Biocept (BIOC) Presents at Rodman & Renshaw Conference

    Biocept, Inc. (NASDAQ: BIOC) is developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test known as a liquid biopsy. Biocept has now developed a unique, patented…

  • Bio-Path Holdings (BPTH) Presents at Rodman & Renshaw Conference

    Bio-Path Holdings, Inc. (NASDAQ: BPTH) is focused on developing therapeutic products that use its proprietary liposomal delivery technology, which is designed to systemically distribute nucleic acid drugs throughout the human body via a simple intravenous…

  • Bio Blast Pharma (ORPN) Presents at Rodman & Renshaw Conference

    Bio Blast Pharma Ltd. (NASDAQ: ORPN) is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. Established in 2012, the company is quickly building a diverse…

  • Bellerophon Therapeutics (BLPH) Presents at Rodman & Renshaw Conference

    Bellerophon Therapeutics LLC (NASDAQ: BLPH)is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Its mission is to develop well-studied molecules deployed…

  • Avita Medical (AVMXY) Presents at Rodman & Renshaw Conference

    Avita Medical Ltd. (OTC: AVMXY) develops and distributes regenerative products to treat a broad range of wounds, scars and skin defects. The company’s patented and proprietary collection and application technology provides innovative treatment solutions derived…

  • Avino Silver & Gold Mines (ASM) Presents at Rodman & Renshaw Conference

    Avino Silver & Gold Mines Ltd. (NYSE: ASM) is a Vancouver-based mining and exploration firm. Founded in 1968, Avino’s mission is to create shareholder value through profitable organic growth at the historic Avino property near…

  • Aurinia Pharmaceuticals (AUPH) Presents at Rodman & Renshaw Conference

    Aurinia Pharmaceuticals, Inc. (NASDAQ: AUPH) is a late-stage biopharmaceutical company focused on the development of the therapeutic immunomodulating drug candidate voclosporin for the treatment of lupus nephritis. The company leverages its team’s past clinical experience…

  • Atossa Genetics (ATOS) Presents at Rodman & Renshaw Conference

    Atossa Genetics Inc. (NASDAQ: ATOS) is focused on improving breast health through the development of innovative laboratory services, medical devices and therapeutics. The company’s laboratory services are being developed by its subsidiary, The National Reference…

  • AsteriasBiotherapeutics (AST) Presents at Rodman & Renshaw Conference

    AsteriasBiotherapeutics, Inc. (NYSE: AST) is a biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry-leading platforms are based on its pluripotent stem cell and allogeneic dendritic cell technologies. Asterias is currently…

  • Ascent Solar Technologies (ASTI) Presents at Rodman & Renshaw Conference

    Ascent Solar Technologies, Inc. (NASDAQ: ASTI) is a developer of thin-film photovoltaic modules with substrate materials that are more flexible, versatile and rugged than traditional solar panels. By pioneering a technology that is recognized as…

  • Arno Therapeutics (ARNI) Presents at Rodman & Renshaw Conference

    Arno Therapeutics, Inc. (OTCQB: ARNI) is a clinical stage biopharmaceutical company developing innovative products for the treatment of cancer and other life threatening diseases. The company has exclusive worldwide rights to develop and market three…

  • Arch Therapeutics (ARTH) Presents at Rodman & Renshaw Conference

    Arch Therapeutics, Inc. (OTCQB: ARTH) is a medical device company developing a novel approach to stop bleeding and control leaking during surgery and trauma care. The company’s innovative self-assembling peptide technology platform has been shown…

  • ARCA biopharma (ABIO) Presents at Rodman & Renshaw Conference

    ARCA biopharma, Inc. (NASDAQ: ABIO) is dedicated to the development of genetically-targeted therapies for cardiovascular diseases. The company’s lead product candidate, bucindolol, is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed to treat…

  • Apricus Biosciences (APRI) Presents at Rodman & Renshaw Conference

    Apricus Biosciences, Inc. (NASDAQ: APRI) is a biopharmaceutical company advancing innovative medicines in urology and rheumatology. The company has initiated a phase IIb trial for fispemifene, a selective estrogen receptor modulator for the treatment of…

  • Aoxing Pharmaceutical Company (AXN) Presents at Rodman & Renshaw Conference

    Aoxing Pharmaceutical Company, Inc. (NYSE: AXN) is a specialty pharmaceutical company operating in China. The company specializes in the research, development, manufacture and distribution of a variety of narcotics and pain-management products. Aoxing currently operates…

  • Amyris (AMRS) Presents at Rodman & Renshaw Conference

    Amyris, Inc. (NASDAQ: AMRS) is an integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Through the application of its innovative bioscience solutions, the company is able to convert…

  • American Lorain (ALN) Presents at Rodman & Renshaw Conference

    American Lorain Corporation (NYSE: ALN) is an international processed snack foods, convenience foods and frozen foods company based in Shandong Province, China. The company recently announced the launch of a new breakfast product line, the…

  • AmpliPhi Biosciences (APHB) Presents at Rodman & Renshaw Conference

    AmpliPhi Biosciences Corporation (OTCQB: APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics. The company’s product development programs target infections that are often resistant to existing antibiotic treatments.…

  • American DG Energy (ADGE) Presents at Rodman & Renshaw Conference

    American DG Energy, Inc. (NYSE: ADGE) is a leading supplier of low-cost energy through the commercialization of its affordable distributed power generating systems. The company’s On-Site Utility™ energy solutions are available without any capital or…

  • Amarin (AMRN) Presents at Rodman & Renshaw Conference

    Amarin Corporation (NASDAQ: AMRN) is a biopharmaceutical company focused on the commercialization and development of therapeutics designed to improve cardiovascular health. The company’s product development program leverages its extensive experience in lipid science and the…

  • AlliquaBioMedical (ALQA) Presents at Rodman & Renshaw Conference

    AlliquaBioMedical, Inc. (NASDAQ: ALQA) is a leading provider of advanced wound care solutions. Through its sales and distribution network, the company provides a suite of technological products that enhance the wound care practitioner’s ability to…

  • Agile Therapeutics (AGRX) Presents at Rodman & Renshaw Conference

    Agile Therapeutics, Inc. (NASDAQ: AGRX) is a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products that provide women with greater convenience and facilitate compliance. The company’s lead…

  • Agenus (AGEN) Presents at Rodman & Renshaw Conference

    Agenus Inc. (NASDAQ: AGEN) is an immunology company focused on the discovery and development of novel checkpoint modulators, vaccines and adjuvants to treat cancer and other diseases. Using its proprietary platforms Retrocyte Display™ and SECANT®,…

  • Aethlon Medical (AEMD) Presents at Rodman & Renshaw Conference

    Aethlon Medical, Inc. (NASDAQ: AEMD) is a leading developer of affinity biofiltrationdevices to treat life-threatening diseases. The company’s lead therapeutic candidate, Aethlon Hemopurifier®, is a first-in-class device that targets the rapid elimination of infectious viruses…

  • AeternaZentaris (AEZS) Presents at Rodman & Renshaw Conference

    AeternaZentaris, Inc. (NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in the development and commercialization of novel treatments in the fields of oncology, endocrinology and women’s health. The company’s product pipeline includes Macrilen™, which is…

  • Aemetis (AMTX) Presents at Rodman & Renshaw Conference

    Aemetis, Inc. (NASDAQ: AMTX) is an advanced renewable fuels and renewable chemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products. The company currently owns and operates a…